LUPKYNIS
Commercial- Indications
- Lupus Nephritis
Company intelligence / Profile preview
Lumira Ventures
Toronto, Ontario, Canadalumiraventures.com ↗
- Ownership
- Private
- Employees
- ~23
- Development stage
- Other
01
Overview
Lumira Ventures does not develop drugs or devices itself but has invested in over 35 approved products across more than 40 diseases through its portfolio. Its investments have led to over $75 billion in cumulative revenue from approved products and impacted over five million patients globally. Portfolio highlights include FDA-approved therapies such as LUPKYNIS™ for lupus nephritis (Aurinia Pharmaceuticals), COSELA® for chemotherapy-induced myelosuppression (G1 Therapeutics), the Cordella™ PA Sensor System for heart failure management (Endotronix), Edison® Histotripsy System for tumor ablation (HistoSonics), among others. Recent investments include Alpha‑9 Oncology’s radiopharmaceutical pipeline and Axonis Therapeutics’ neurology programs.
- Modalities
- Small moleculeMonoclonal antibodyMedical deviceRadiopharmaceuticalsDigital health solutions
- Industry
- Investors
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Merck Lumira Biosciences Strategic FundAngelini Lumira Biosciences Strategic FundHospital foundations through philanthropic initiativesLightspeed Venture PartnersCormorant Asset Management
Beyond the preview
Go deeper on Lumira Ventures.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lumira Ventures.